Gleason Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Gleason Group's BMY Position: Q2 2026 in Review
Gleason Group reduced its Bristol-Myers Squibb (BMY) stake by 50% in Q2 2026, selling an estimated $5.68K and leaving 101 shares worth $5.82K. The position accounts for ﹤0.01% of the portfolio, ranked #302.
Gleason Group first reported a position in BMY in Q2 2024 and has held it in 3 quarters since. The position peaked at $12.1K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Gleason Group held 101 shares of Bristol-Myers Squibb worth $5.82K as of Q2 2026.
- Gleason Group sold 99 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.68K.
- Bristol-Myers Squibb made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #302 holding.
- Gleason Group first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 3 quarters since.
- Gleason Group's Bristol-Myers Squibb position peaked at $12.1K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.